These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1311867)

  • 1. Kaposi's sarcoma gives on key fronts.
    Palca J
    Science; 1992 Mar; 255(5050):1352-4. PubMed ID: 1311867
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
    Miles SA; Martínez-Maza O; Rezai A; Magpantay L; Kishimoto T; Nakamura S; Radka SF; Linsley PS
    Science; 1992 Mar; 255(5050):1432-4. PubMed ID: 1542793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.
    Nair BC; DeVico AL; Nakamura S; Copeland TD; Chen Y; Patel A; O'Neil T; Oroszlan S; Gallo RC; Sarngadharan MG
    Science; 1992 Mar; 255(5050):1430-2. PubMed ID: 1542792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enigma of Kaposi's sarcoma: an answer at last?
    Wolff K
    Clin Exp Dermatol; 1992 May; 17(3):146-51. PubMed ID: 1451286
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation.
    Guo WX; Gill PS; Antakly T
    Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.
    Cai J; Gill PS; Masood R; Chandrasoma P; Jung B; Law RE; Radka SF
    Am J Pathol; 1994 Jul; 145(1):74-9. PubMed ID: 8030759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
    Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
    J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection of human gastrointestinal submucosal cells: an in vitro model that mimics Kaposi's sarcoma.
    Moyer MP; Ramirez A; Woolf A; Huot RI; McKee-Suarez MS
    In Vitro Cell Dev Biol; 1991 Apr; 27A(4):337-44. PubMed ID: 1713204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in understanding Kaposi's sarcoma.
    Oncology (Williston Park); 1989 Jan; 3(1):106-7. PubMed ID: 2641304
    [No Abstract]   [Full Text] [Related]  

  • 11. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
    Murakami-Mori K; Mori S; Nakamura S
    J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis.
    Stürzl M; Brandstetter H; Zietz C; Eisenburg B; Raivich G; Gearing DP; Brockmeyer NH; Hofschneider PH
    Oncogene; 1995 May; 10(10):2007-16. PubMed ID: 7761101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma.
    Nickoloff BJ; Huang YQ; Li JJ; Friedman-Kien AE
    Lancet; 1992 Feb; 339(8792):548-9. PubMed ID: 1346890
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
    Amaral MC; Miles S; Kumar G; Nel AE
    J Clin Invest; 1993 Aug; 92(2):848-57. PubMed ID: 7688764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma.
    Dalgleish AG
    Br J Cancer; 1991 Jul; 64(1):3-6. PubMed ID: 1854625
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure to detect human papillomavirus in Kaposi's sarcoma.
    Biggar RJ; Dunsmore N; Kurman RJ; Shah KV; Kordor J; Cottoni F; Hatzakis A; Gigase PL
    Lancet; 1992 Jun; 339(8809):1604-5. PubMed ID: 1351572
    [No Abstract]   [Full Text] [Related]  

  • 17. Infectious agent for Kaposi's?
    Lancet; 1992 Feb; 339(8792):505. PubMed ID: 1346875
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.
    Guo WX; Antakly T
    Am J Pathol; 1995 Mar; 146(3):727-34. PubMed ID: 7887453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma and variably acid-fast bacteria in vivo in two homosexual men.
    Cantwell AR
    Cutis; 1983 Jul; 32(1):58-61, 63-4, 68. PubMed ID: 6884084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.